Cargando…
Editorial: Targeted Immunotherapy for Cancer
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041305/ https://www.ncbi.nlm.nih.gov/pubmed/35496284 http://dx.doi.org/10.3389/fphar.2022.894681 |
_version_ | 1784694517955297280 |
---|---|
author | Williams, Williams V. |
author_facet | Williams, Williams V. |
author_sort | Williams, Williams V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9041305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90413052022-04-27 Editorial: Targeted Immunotherapy for Cancer Williams, Williams V. Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-12 /pmc/articles/PMC9041305/ /pubmed/35496284 http://dx.doi.org/10.3389/fphar.2022.894681 Text en Copyright © 2022 Williams. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Williams, Williams V. Editorial: Targeted Immunotherapy for Cancer |
title | Editorial: Targeted Immunotherapy for Cancer |
title_full | Editorial: Targeted Immunotherapy for Cancer |
title_fullStr | Editorial: Targeted Immunotherapy for Cancer |
title_full_unstemmed | Editorial: Targeted Immunotherapy for Cancer |
title_short | Editorial: Targeted Immunotherapy for Cancer |
title_sort | editorial: targeted immunotherapy for cancer |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041305/ https://www.ncbi.nlm.nih.gov/pubmed/35496284 http://dx.doi.org/10.3389/fphar.2022.894681 |
work_keys_str_mv | AT williamswilliamsv editorialtargetedimmunotherapyforcancer |